BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 19305646)

  • 41. A novel peroxynitrite decomposer catalyst (FP-15) reduces myocardial infarct size in an in vivo peroxynitrite decomposer and acute ischemia-reperfusion in pigs.
    Bianchi C; Wakiyama H; Faro R; Khan T; McCully JD; Levitsky S; Szabó C; Sellke FW
    Ann Thorac Surg; 2002 Oct; 74(4):1201-7. PubMed ID: 12400769
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid NOS-1-derived nitric oxide and peroxynitrite formation act as signaling agents for inducible NOS-2 expression in vascular smooth muscle cells.
    Scheschowitsch K; de Moraes JA; Sordi R; Barja-Fidalgo C; Assreuy J
    Pharmacol Res; 2015 Oct; 100():73-84. PubMed ID: 26253183
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Superoxide- and nitric oxide-derived species mediate endothelial dysfunction, endothelial glycocalyx disruption, and enhanced neutrophil adhesion in the post-ischemic guinea-pig heart.
    Kurzelewski M; Czarnowska E; Beresewicz A
    J Physiol Pharmacol; 2005 Jun; 56(2):163-78. PubMed ID: 15985700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels.
    Guzik TJ; West NE; Pillai R; Taggart DP; Channon KM
    Hypertension; 2002 Jun; 39(6):1088-94. PubMed ID: 12052847
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peroxynitrite in myocardial ischemia-reperfusion injury.
    Lalu MM; Wang W; Schulz R
    Heart Fail Rev; 2002 Oct; 7(4):359-69. PubMed ID: 12379821
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 4-Hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (Tempol) inhibits peroxynitrite-mediated phenol nitration.
    Carroll RT; Galatsis P; Borosky S; Kopec KK; Kumar V; Althaus JS; Hall ED
    Chem Res Toxicol; 2000 Apr; 13(4):294-300. PubMed ID: 10775330
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress.
    Tao L; Gao E; Jiao X; Yuan Y; Li S; Christopher TA; Lopez BL; Koch W; Chan L; Goldstein BJ; Ma XL
    Circulation; 2007 Mar; 115(11):1408-16. PubMed ID: 17339545
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of a novel guanylyl cyclase inhibitor on the vascular actions of nitric oxide and peroxynitrite in immunostimulated smooth muscle cells and in endotoxic shock.
    Zingarelli B; Haskó G; Salzman AL; Szabó C
    Crit Care Med; 1999 Sep; 27(9):1701-7. PubMed ID: 10507586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of myocardial nitric oxide in diabetic ischemia-reperfusion dysfunction: studies in mice with myocyte-specific overexpression of endothelial nitric-oxide synthase.
    Pozo-Navas B; Stessel H; Wölkart G; Brunner F
    J Pharmacol Exp Ther; 2006 Nov; 319(2):729-38. PubMed ID: 16857730
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nitric oxide and peroxynitrite in postischemic myocardium.
    Zweier JL; Fertmann J; Wei G
    Antioxid Redox Signal; 2001 Feb; 3(1):11-22. PubMed ID: 11294189
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts.
    Yasmin W; Strynadka KD; Schulz R
    Cardiovasc Res; 1997 Feb; 33(2):422-32. PubMed ID: 9074708
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly.
    Beckman JS; Koppenol WH
    Am J Physiol; 1996 Nov; 271(5 Pt 1):C1424-37. PubMed ID: 8944624
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peroxynitrite inhibition of nitric oxide synthases.
    Pasquet JP; Zou MH; Ullrich V
    Biochimie; 1996; 78(8-9):785-91. PubMed ID: 9010608
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide.
    Pryor WA; Squadrito GL
    Am J Physiol; 1995 May; 268(5 Pt 1):L699-722. PubMed ID: 7762673
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury.
    Cuzzocrea S; Riley DP; Caputi AP; Salvemini D
    Pharmacol Rev; 2001 Mar; 53(1):135-59. PubMed ID: 11171943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of peroxynitrite-induced renal injury through modulation of peroxynitrite production by the Chinese prescription Wen-Pi-Tang.
    Rhyu DY; Yokozawa T; Choa EJ; Park JC
    Free Radic Res; 2002 Dec; 36(12):1261-9. PubMed ID: 12607816
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nitric oxide and cardioprotection during ischemia-reperfusion.
    Jugdutt BI
    Heart Fail Rev; 2002 Oct; 7(4):391-405. PubMed ID: 12379824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Agonist-induced peroxynitrite production from endothelial cells.
    Kooy NW; Royall JA
    Arch Biochem Biophys; 1994 May; 310(2):352-9. PubMed ID: 8179319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peroxynitrite: mediator of the toxic action of nitric oxide.
    Bartosz G
    Acta Biochim Pol; 1996; 43(4):645-59. PubMed ID: 9104501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of nicaraven on nitric oxide-related pathways and in shock and inflammation.
    Zingarelli B; Scott GS; Hake P; Salzman AL; Szabo C
    Shock; 2000 Feb; 13(2):126-34. PubMed ID: 10670842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.